Dr. Rami George Alrabaa, MD

Dr. Alrabaa practices at Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health.

Dr. Alrabaa's NPI, 1336503267, was assigned on April 6, 2016. Dr. Alrabaa graduated from Rutgers New Jersey Medical School in 2016. Dr. Alrabaa's New Jersey license number on file is 25MA11466500.

Dr. Alrabaa's primary practice is Englewood Hospital, at 350 Engle St, Englewood, NJ 07631 in Bergen County. The practice phone is (201) 894-3000.

Dr. Alrabaa's primary practice is Englewood Hospital in Englewood, New Jersey, part of RWJBarnabas Health. Dr. Alrabaa is also affiliated with St. Joseph's University Medical Center. The medical group on file is Medical Associates at Englewood. Dmand AI also links Dr. Alrabaa to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alrabaa practices, 5 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Alrabaa's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dr. Alrabaa is board certified in orthopaedic surgery by the American Board of Orthopaedic Surgery. Dmand AI has Dr. Alrabaa's licenses on file in 2 states: New Jersey and California.

Dmand AI lists arm, wrist, hand fracture and dislocation, arthritis, broken or dislocated ankle/ or foot, bursitis, enthesopathy in arms, joint pain, knee fracture and dislocation and knee injury among the conditions Dr. Alrabaa treats.

CMS data shows 1,734 Medicare services from Dr. Alrabaa across 13 procedure codes in 2024, for 348 Medicare patients. Medicare paid $103,832 for them.

CMS counts 348 Medicare patients who saw Dr. Alrabaa in 2024. The largest group is 65 to 74, with 152 patients. 75% of them have arthritis, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.34, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Alrabaa's median patient age at 62, with 61% women.

In 2024, Dr. Alrabaa wrote 527 Medicare Part D claims for 381 patients. 100% of them were for generic drugs. CMS names the drug for 481 of them, across 8 drugs with 11 or more claims each, at $7,848 in total drug cost. In 2023, CMS named 402 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Alrabaa for performance year 2024, reported through an alternative payment model (APM). Dr. Alrabaa accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Alrabaa, more than 66% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Alrabaa, published from 2011 to 2023. 2022 was the busiest year, with 7. The most frequent topics are Postoperative Complications, Rupture and Tendon Injuries. Dr. Alrabaa has published most often in Arthrosc Tech. Dr. Alrabaa's most frequent co-authors are David Paolo Trofa, MD, Alan Lingqi Zhang, MD and Christopher Ahmad, MD.

CMS Open Payments shows 87 general payments to Dr. Alrabaa from 22 drug and device companies from 2021 to 2025. Grants make up the largest share, 37% of the total. Medical Device Business Services, Inc. paid the most, $8,184.

Dr. Alrabaa graduated from Rutgers New Jersey Medical School in 2016.

Dr. Alrabaa is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.